1. MicroRNA hsa-miR-150-5p inhibits nasopharyngeal carcinogenesis by suppressing PYCR1 (pyrroline-5-carboxylate reductase 1)
- Author
-
Xiaoliu Zhou, Xuejun Zhou, Zhencai Xu, Junwei Yang, Chengliang Xing, Zhiqun Li, and Jiajun Huang
- Subjects
Carcinogenesis ,nasopharyngeal cancer ,Bioengineering ,medicine.disease_cause ,Applied Microbiology and Biotechnology ,Downregulation and upregulation ,Cell Line, Tumor ,miR-150 ,microRNA ,medicine ,Humans ,RNA, Neoplasm ,Viability assay ,Chemistry ,Cell growth ,Nasopharyngeal Neoplasms ,General Medicine ,PYCR1 ,Neoplasm Proteins ,body regions ,MicroRNAs ,Real-time polymerase chain reaction ,Hsa-miR-150-5p ,Apoptosis ,embryonic structures ,Cancer research ,Pyrroline Carboxylate Reductases ,TP248.13-248.65 ,Research Article ,Research Paper ,Biotechnology - Abstract
Nasopharyngeal cancer is a rare cancer type, but with a low five-year survival rate. Dysregulation of pyrroline-5-carboxylate reductase 1 (PYCR1) and microRNA hsa-miR-150-5p is involved in the development of various cancers. However, the molecular mechanism of the hsa-miR-150-5p-PYCR1 axis in nasopharyngeal cancer remains unclear. To identify the mechanism of the hsa-miR-150-5p-PYCR1 axis, the expression of hsa-miR-150-5p and PYCR1 in nasopharyngeal cancer tissues and cells was first measured by reverse transcription quantitative polymerase chain reaction. The luciferase and RNA pull-down assays were used to confirm the interaction between hsa-miR-150-5p and PYCR1. The overexpression of hsa-miR-150-5p and PYCR1 was detected by cell viability, proliferation, western blotting, migration, and invasion in nasopharyngeal cancer cells. The expression levels of hsa-miR-150-5p was reduced in the nasopharyngeal cancer tissues and cells and were negatively correlated with the PYCR1 levels. The upregulation of hsa-miR-150-5p significantly repressed cell growth and promoted apoptosis. However, the upregulation of PYCR1 expression significantly promoted nasopharyngeal carcinogenesis, which could abolish the inhibitory effect of hsa-miR-150-5p. In conclusion, we clarified that hsa-miR-150-5p attenuated nasopharyngeal carcinogenesis by reducing the PYCR1 expression levels. This provides a new perspective of nasopharyngeal cancer involving both hsa-miR-150-5p and PYCR1 for the treatment of nasopharyngeal cancer.
- Published
- 2021
- Full Text
- View/download PDF